Lymphocyte-Activation Gene 3 (LAG3) (C-Term) Peptide
LAG3
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all LAG3 products
- LAG3 (Lymphocyte-Activation Gene 3 (LAG3))
- Protein Region
- C-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- GFHLWRRQWR PRRFSALEQG IHPPQAQSKI EELEQEPEPE PEPEPEPEPE
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-LAG3 Antibody(ARP59142_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- LAG3 (Lymphocyte-Activation Gene 3 (LAG3))
- Background
-
Lymphocyte-activation protein 3 belongs to Ig superfamily and contains 4 extracellular Ig-like domains. The LAG3 gene contains 8 exons. The sequence data, exon/intron organization, and chromosomal localization all indicate a close relationship of LAG3 to CD4.
Alias Symbols: CD223
Protein Interaction Partner: CEBPZ,CENPJ
Protein Size: 525 - Molecular Weight
- 55 kDa
- Gene ID
- 3902
- NCBI Accession
- NM_002286, NP_002277
- UniProt
- P18627
-
You are here:
